Takeda To Report First Increase In Operating Profit In Four Years
This article was originally published in PharmAsia News
Executive Summary
After four years without an increase in operating profit, Takeda Pharmaceutical expects to report one for the fiscal year just completed, amounting to $1.56 billion, or 30%, beating the forecast amount.